TABLE 1.

Clinical data of 17 cefozopran-resistant N. gonorrhoeae isolates^a

Strain no.	Hospital IDb	Age (yr) and sex of patientc	First treatment			Final treatment
			Agentsd	Regimene	Clinical outcome	Agent(s)	Regimen	Clinical outcome
SNG27	Ue	27, M	CDR	100 mg × 3, p.o., 3 days	Failure	CRO	1 g i.v., single dose	Cure
						SPX	100 mg, 3 days
SNG28	Ya	24, M	SPT	2 g i.m., single dose	Cure
			DOX	100 mg × 2, p.o., 7 days
SNG32	Ar	19, F	CM	Suppository, 2 times	Not tested
SNG33	UO	29, M	AZT	1 g i.v., single dose	Failure	SPT	2 g i.m., single dose	Cure
SNG46	Ya	21, M	SPT	2 g i.m., single dose	Cure
			DOX	100 mg × 2, p.o., 7 days
SNG50	Ni	19, M	CDR	100 mg × 3, p.o., 3 days	Failure	SPT	2 g i.m., single dose	NF
SNG52	An	22, F	AMO	375 mg × 4, p.o., 7 days	Failure	CDZ	1 g i.v., single dose	Cure
SNG53	Kr	24, M	CRO	1 g i.v., single dose	Cure
SNG54	AY	42, M	LVX	100 mg × 3, p.o.	Failure	CDZ	1 g i.v., single dose	Cure
SNG57	BM	36, M	Unknown
SNG65	Ni	19, M	CDR	100 mg × 3, 3 days	NFf
SNG70	BM	33, M	Unknown
SNG74	Ni	30, M	SPT	2 g i.m., single dose	Cure
			MIN	100 mg × 2, 7 days
SNG75	Ni	27, M	SPT	2 g i.m., single dose	Cure
			MIN	100 mg × 2, p.o., 7 days
SNG76	Ni	29, M	CDZ	1 g i.v., single dose	Cure
SNG79	Ni	26, M	CDZ	1 g i.v., single dose	Cure
SNG81	An	19, M	CDZ	1 g i.v., single dose	Cure

^aIncluding isolates from clinical failure cases treated with CDR and AZT. Data for SNG27 and SNG33 have been previously reported (1). 

^bBlind names of hospitals. 

^cM, male; F, female. 

^dCDR, cefdinir; DOX, doxycycline; MIN, minocycline; AMO, amoxicillin; SPX, sparfloxacin. 

^ep.o., orally; i.m., intramuscularly; i.v., intravenously. 

^fNF, not followed.